{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T11:46:52Z","timestamp":1794656812037,"version":"4.9.1"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVES:<\/jats:title>\n                    <jats:p>The aim of this study was to evaluate the association between preoperative proton pump inhibitor (PPI) use and postoperative outcomes after pelvic fracture fixation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>Retrospective cohort study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting:<\/jats:title>\n                    <jats:p>TriNetX Research Network, a federated database of electronic medical records from approximately 103 health care organizations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient Selection Criteria:<\/jats:title>\n                    <jats:p>Adult patients of 18 years of age and older who underwent surgical fixation of pelvic fractures between 2000 and 2023 were identified. All operatively managed pelvic fracture types were included, encompassing OTA\/AO classifications 61 A\u2013C; however, specific fracture classification was not available within the database. Patients were stratified into cohorts based on preoperative PPI use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcome Measures and Comparisons:<\/jats:title>\n                    <jats:p>Postoperative outcomes, including sepsis, revision surgery, hardware removal, nonunion, and malunion, were compared between patients with and without preoperative PPI use at 90 days and 2 years after surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      Before matching, 2648 patients were included in the preoperative PPI cohort and 7655 patients in the control cohort. After propensity score matching, 2403 patients remained in each cohort. The mean age was 44.0 \u00b1 17.3 years in the PPI cohort and 43.7 \u00b1 17.0 years in the control cohort, with 37.3% and 38.6% female patients, respectively. At 90 days postoperatively, preoperative PPI use was associated with increased risks of sepsis [risk ratio (RR) 1.48, 95% confidence interval (CI), 1.07\u20132.06,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.017], deep vein thrombosis (RR 1.58, 95% CI, 1.11\u20132.23,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.010), revision surgery (RR 1.69, 95% CI, 1.28\u20132.22,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), and hardware removal (RR 1.58, 95% CI, 1.20\u20132.08,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001). At 2 years, preoperative PPI use remained associated with increased risk of revision surgery (RR 1.66, 95% CI, 1.27\u20132.15,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), and nonunion (RR 1.71, 95% CI, 1.10\u20132.65,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.015) and hardware removal (RR 1.17, 95% CI, 1.01\u20131.36,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.039). No other significant differences were observed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>Preoperative PPI use was associated with increased risks of both short-term complications and long-term adverse outcomes after pelvic fracture fixation, including higher rates of sepsis, nonunion, malunion, and revision surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>LEVEL OF EVIDENCE:<\/jats:title>\n                    <jats:p>Level III, Prognostic.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/bot.0000000000003219","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T18:02:30Z","timestamp":1778004150000},"page":"e233-e237","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Preoperative Proton Pump Inhibitor Use Was Associated With Increased Risk of Revision Surgery and Impaired Bone Healing After Pelvic Fracture Fixation: A Retrospective Cohort Study"],"prefix":"10.1097","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8967-8296","authenticated-orcid":false,"given":"Joshua","family":"Wang","sequence":"first","affiliation":[{"name":"John Sealy School of Medicine, The University of Texas Medical Branch, Galveston, TX; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmerson","family":"McGowan","sequence":"additional","affiliation":[{"name":"John Sealy School of Medicine, The University of Texas Medical Branch, Galveston, TX; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4947-772X","authenticated-orcid":false,"given":"Keenan","family":"Horani","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery and Rehabilitation, The University of Texas Medical Branch, Galveston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9864-7827","authenticated-orcid":false,"given":"John C.","family":"Hagedorn","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery and Rehabilitation, The University of Texas Medical Branch, Galveston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260918","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMcp2114026","article-title":"Gastroesophageal reflux disease","volume":"387","author":"Fass","year":"2022","journal-title":"N Engl J Med"},{"key":"R2-20260918","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12916-016-0724-1","article-title":"Inhibiting the proton pump: mechanisms, benefits, harms, and questions","volume":"14","author":"Aronson","year":"2016","journal-title":"BMC Med"},{"key":"R3-20260918","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2165\/00003495-199856030-00002","article-title":"Proton pump inhibitors. Pharmacology and rationale for use in gastrointestinal disorders","volume":"56","author":"Richardson","year":"1998","journal-title":"Drugs"},{"key":"R4-20260918","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.phrs.2008.09.016","article-title":"Proton pump inhibitors in GORD an overview of their pharmacology, efficacy and safety","volume":"59","author":"Savarino","year":"2009","journal-title":"Pharmacol Res"},{"key":"R5-20260918","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1152\/physrev.00016.2019","article-title":"The physiology of the gastric parietal cell","volume":"100","author":"Engevik","year":"2020","journal-title":"Physiol Rev"},{"key":"R6-20260918","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s11894-008-0098-4","article-title":"Pharmacology of proton pump inhibitors","volume":"10","author":"Shin","year":"2008","journal-title":"Curr Gastroenterol Rep"},{"key":"R7-20260918","doi-asserted-by":"crossref","first-page":"e70057","DOI":"10.1111\/bcpt.70057","article-title":"Trends in proton-pump inhibitor use among Danish adults: a nationwide drug utilization study 2015-2023","volume":"137","author":"Lundgaard","year":"2025","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"R8-20260918","first-page":"30476","article-title":"National trends in prescription proton pump inhibitor use and expenditure in the United States in 2002-2017","volume":"S1544-3191","author":"Mishuk","year":"2020","journal-title":"J Am Pharm Assoc (2003)"},{"key":"R9-20260918","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s00228-023-03534-z","article-title":"Proton pump inhibitor use: systematic review of global trends and practices","volume":"79","author":"Shanika","year":"2023","journal-title":"Eur J Clin Pharmacol"},{"key":"R10-20260918","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/bcpt.13023","article-title":"Side effects of long-term proton pump inhibitor use: a review","volume":"123","author":"Haastrup","year":"2018","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"R11-20260918","doi-asserted-by":"crossref","first-page":"27","DOI":"10.14309\/ajg.0000000000001538","article-title":"ACG clinical guideline for the diagnosis and management of gastroesophageal reflux disease","volume":"117","author":"Katz","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"R12-20260918","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/ajhp\/zxad009","article-title":"Proton pump inhibitors: understanding the associated risks and benefits of long-term use","volume":"80","author":"Thurber","year":"2023","journal-title":"Am J Health Syst Pharm"},{"key":"R13-20260918","doi-asserted-by":"crossref","first-page":"105714","DOI":"10.1016\/j.jbspin.2024.105714","article-title":"Proton pump inhibitors, bone and phosphocalcic metabolism","volume":"91","author":"Philippoteaux","year":"2024","journal-title":"Joint Bone Spine"},{"key":"R14-20260918","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.3390\/ijerph16091571","article-title":"Proton pump inhibitors and fracture risk: a review of current evidence and mechanisms involved","volume":"16","author":"Thong","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"R15-20260918","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41584-022-00887-0","article-title":"The decisive early phase of bone regeneration","volume":"19","author":"Duda","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"R16-20260918","doi-asserted-by":"crossref","first-page":"8902367","DOI":"10.1155\/2021\/8902367","article-title":"Proton pump inhibitors and fractures in adults: a critical appraisal and review of the literature","volume":"2021","author":"Briganti","year":"2021","journal-title":"Int J Endocrinol"},{"key":"R17-20260918","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.lfs.2018.12.058","article-title":"Proton pump inhibitors therapy and risk of bone diseases: an update meta-analysis","volume":"218","author":"Liu","year":"2019","journal-title":"Life Sci"},{"key":"R18-20260918","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1007\/s00198-023-06867-8","article-title":"The association between proton pump inhibitors and hyperparathyroidism: a potential mechanism for increased fracture-results of a large observational cohort study","volume":"34","author":"Fitzpatrick","year":"2023","journal-title":"Osteoporos Int"},{"key":"R19-20260918","first-page":"70","article-title":"Osteoporotic pelvic fractures","volume":"115","author":"Oberkircher","year":"2018","journal-title":"Dtsch Arztebl Int"},{"key":"R20-20260918","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.archger.2016.06.020","article-title":"Risk factors for pelvic insufficiency fractures and outcome after conservative therapy","volume":"67","author":"Maier","year":"2016","journal-title":"Arch Gerontol Geriatr"},{"key":"R21-20260918","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1097\/TA.0000000000003398","article-title":"Demographic changes in pelvic fracture patterns at a Swiss academic trauma center from 2007 to 2017","volume":"92","author":"Villiger","year":"2022","journal-title":"J Trauma Acute Care Surg"},{"key":"R22-20260918","doi-asserted-by":"crossref","first-page":"117225","DOI":"10.1016\/j.bone.2024.117225","article-title":"Clinical frailty and short-term outcomes after low-energy pelvic fracture in the geriatric population: nationwide inpatient sample 2016-2018 analysis","volume":"188","author":"Lo","year":"2024","journal-title":"Bone"},{"key":"R23-20260918","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1186\/s12891-021-04579-w","article-title":"Operative management of fragility fractures of the pelvis - a systematic review","volume":"22","author":"Wilson","year":"2021","journal-title":"BMC Musculoskelet Disord"},{"key":"R24-20260918","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.3390\/jcm14092935","article-title":"Fragility fractures of the pelvic ring: analysis of epidemiology, treatment concepts, and surgical strategies from the registry of the German Pelvic Multicenter Study Group","volume":"14","author":"Osche","year":"2025","journal-title":"J Clin Med"},{"key":"R25-20260918","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s11914-022-00760-9","article-title":"Fragility fractures of the pelvis: current practices and future directions","volume":"20","author":"Hutchings","year":"2022","journal-title":"Curr Osteoporos Rep"},{"key":"R26-20260918","doi-asserted-by":"crossref","first-page":"112594","DOI":"10.1016\/j.injury.2025.112594","article-title":"Research mapping of trends in conservative management and outcomes of fragility fractures of the pelvis","volume":"56","author":"Endo","year":"2025","journal-title":"Injury"},{"key":"R27-20260918","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13017-017-0117-6","article-title":"Pelvic trauma: WSES classification and guidelines","volume":"12","author":"Coccolini","year":"2017","journal-title":"World J Emerg Surg"},{"key":"R28-20260918","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1080\/17453674.2021.1920687","article-title":"Proton-pump inhibitors are associated with increased risk of prosthetic joint infection in patients with total hip arthroplasty: a case-cohort study","volume":"92","author":"Bruin","year":"2021","journal-title":"Acta Orthop"},{"key":"R29-20260918","doi-asserted-by":"crossref","first-page":"E400","DOI":"10.1097\/BSD.0000000000001749","article-title":"The impact of proton pump inhibitor use on fusion rates following single-level anterior cervical discectomy and fusion","volume":"38","author":"Chang","year":"2025","journal-title":"Clin Spine Surg"},{"key":"R30-20260918","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1080\/03602532.2019.1610767","article-title":"The impact of proton pump inhibitors on bone regeneration and implant osseointegration","volume":"51","author":"Mester","year":"2019","journal-title":"Drug Metab Rev"},{"key":"R31-20260918","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1001\/jama.2009.722","article-title":"Acid-suppressive medication use and the risk for hospital-acquired pneumonia","volume":"301","author":"Herzig","year":"2009","journal-title":"JAMA"},{"key":"R32-20260918","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.atherosclerosis.2018.08.035","article-title":"Use of proton pump inhibitors and risk of ischemic events in the general population","volume":"277","author":"Casula","year":"2018","journal-title":"Atherosclerosis"},{"key":"R33-20260918","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/phar.2504","article-title":"Association of proton pump inhibitor use with endothelial function and metabolites of the nitric oxide pathway: a cross-sectional study","volume":"41","author":"Nolde","year":"2021","journal-title":"Pharmacotherapy"},{"key":"R34-20260918","doi-asserted-by":"crossref","first-page":"131567","DOI":"10.1016\/j.ijcard.2023.131567","article-title":"Association between regular proton pump inhibitors use and cardiovascular outcomes: a large prospective cohort study","volume":"395","author":"Li","year":"2024","journal-title":"Int J Cardiol"},{"key":"R35-20260918","doi-asserted-by":"crossref","first-page":"10733","DOI":"10.3390\/ijms231810733","article-title":"Proton pump inhibitors and bone health: an update narrative review","volume":"23","author":"Lespessailles","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R36-20260918","doi-asserted-by":"crossref","first-page":"22376","DOI":"10.1038\/s41598-020-79605-3","article-title":"Pantoprazole impairs fracture healing in aged mice","volume":"10","author":"Menger","year":"2020","journal-title":"Sci Rep"},{"key":"R37-20260918","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s00223-021-00882-9","article-title":"Proton pump inhibitors inhibit PHOSPHO1 activity and matrix mineralisation in vitro","volume":"109","author":"Staines","year":"2021","journal-title":"Calcif Tissue Int"}],"container-title":["Journal of Orthopaedic Trauma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/BOT.0000000000003219","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T11:00:15Z","timestamp":1789729215000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/BOT.0000000000003219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/bot.0000000000003219","relation":{},"ISSN":["0890-5339","1531-2291"],"issn-type":[{"value":"0890-5339","type":"print"},{"value":"1531-2291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"2026-04-23","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}